Sector Chart BioCryst Pharmaceuticals, Inc.

Stocks

BCRX

US09058V1035

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-06-25 EDT 5-day change 1st Jan Change
9.900 USD -1.00% Intraday chart for BioCryst Pharmaceuticals, Inc. +10.12% +26.92%
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales Growth Profitability Finances EV / Sales P/E
2.54B - - -
52.88B
50.98B
22.81B -
22.43B -
17.01B